Debevoise & Plimpton LLP has advised Clayton, Dubilier & Rice in the financing aspects in its acquisition, together with TowerBrook Capital Partners, of R1 RCM Inc. (NASDAQ: RCM) (“R1”), at an enterprise value of $8.9 billion. For more information, please see the client’s press release.

The financing included an offering of 6.875% senior secured notes with an aggregate amount of $1.3 billion due 2031, a $2.8 billion Senior Secured Term Loan Facility, a $687.5 million Senior Secured Revolving Facility and a $200 million Senior Secured Delayed Draw Term Loan Facility.

R1 is a provider of technology-driven solutions that impact the patient experience and financial performance of healthcare providers.

The Debevoise team was led by capital markets partner Morgan Hayes and finance partner Scott Selinger and included capital markets counsel Joshua Samit, associates Julia Glazer, John Jacob, Paul Lowry and Maayan Stein and law clerk Brett Edelblum, finance partner Brett Novick, counsel Zahra Sowder and associates Max Lovrin, Matthew Tolson, Jonathan Yeung and Hanson Yu, M&A partners Christopher Anthony and Katherine Durnan Taylor and associates Alexander Altieri, Marisa Demko, Devon Donohue and Elina Sigal, investment management partners Jonathan Adler and Jason Auerbach and associates Carly Hill, Andrew Silvia and Jihyun Yoo, and tax counsel Adam Namm and associates Shanna Adler and Robert Nelson-Sullivan.